Receptor protein tyrosine phosphatase alpha signaling is involved in androgen depletion-induced neuroendocrine differentiation of androgen-sensitive LNCaP human prostate cancer cells

Oncogene

Volumn 22, Issue 42 REV. ISS. 4, 2003, Pages 6704-6716

  Zhang, Xiu Qing ^a   Kondrikov, Dmitry ^a   Yuan, Ta Chun ^a   Lin, Fen Fen ^a   Hansen, Joel ^a   Lin, Ming Fong ^a,b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Androgen ablation; ERK MAPK; Neuroendocrine differentiation; Prostate cancer; Receptor protein tyrosine phosphatase alpha

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ANDROGEN; COMPLEMENTARY DNA; MITOGEN ACTIVATED PROTEIN KINASE; NEURON SPECIFIC ENOLASE; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE ALPHA; RECEPTOR PROTEIN; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; ENOLASE; ENZYME INHIBITOR; FLAVONOID; GREEN FLUORESCENT PROTEIN; LEUKOCYTE COMMON ANTIGEN RELATED PHOSPHATASE; LEUKOCYTE COMMON ANTIGEN-RELATED PHOSPHATASE; PHOTOPROTEIN;

ANDROGEN THERAPY; ARTICLE; CANCER CELL; CELL CLONE; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA TRANSFECTION; GENE EXPRESSION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; NERVE CELL DIFFERENTIATION; NEUROSECRETORY CELL; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; SIGNAL TRANSDUCTION; BIOLOGICAL MODEL; BIOSYNTHESIS; CELL CULTURE; CELL DIVISION; ENZYME ACTIVATION; FLUORESCENCE MICROSCOPY; MALE; METABOLISM; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROSTATE TUMOR; TIME; WESTERN BLOTTING;

ANDROGENS; BLOTTING, WESTERN; CELL DIFFERENTIATION; CELL DIVISION; DNA, COMPLEMENTARY; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; ENZYME INHIBITORS; FLAVONOIDS; GREEN FLUORESCENT PROTEINS; HUMANS; LUMINESCENT PROTEINS; MALE; MICROSCOPY, FLUORESCENCE; MITOGEN-ACTIVATED PROTEIN KINASES; MODELS, BIOLOGICAL; PHOSPHOPYRUVATE HYDRATASE; PROSTATIC NEOPLASMS; PROTEIN-TYROSINE-PHOSPHATASE; RECEPTORS, CELL SURFACE; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0242690301     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1206764     Document Type: Article

References (86)

1. Abrahamsson PA. (1999a). Prostate, 39, 135-148.
2. Abrahamsson PA. (1999b). Endocr. Relat. Cancer, 6, 503-519.
3. Abrahamsson PA and Lilja H. (1989). Prostate, 14, 71-81.
4. Almagro UA, Tieu TM, Remeniuk E, Kueck B and Strumpf K. (1986). Arch. Pathol. Lab. Med., 110, 916-919.
5. Bang YJ, Pirnia F, Fang WG, Kang WK, Sartor O, Whitesell L, Ha MJ, Tsokos M, Sheahan MD and Nguyen P. (1994). Proc. Natl. Acad. Sci. USA, 91, 5330-5334.
6. Bennett AM and Tonks NK. (1997). Science, 278, 1288-1291.
7. Bologna M, Festuccia C, Muzi P, Biordi L and Ciomei M. (1989). Cancer, 63, 1714-1720.
8. Bonkhoff H. (1998). Prostate Suppl., 8, 18-22.
9. Bonkhoff H and Remberger K. (1996). Prostate, 28, 98-106.
10. Bonkhoff H, Wernert N, Dhom G and Remberger K. (1991). Prostate, 19, 91-98.
11. Burchardt T, Burchardt M, Chen MW, Cao Y, de_la_Taille A, Shabsigh A, Hayek O, Dorai T and Buttyan R. (1999). J. Urol., 162, 1800-1805.
12. Chen T, Cho RW, Stork PJ and Weber MJ. (1999). Cancer Res., 59, 213-218.
13. Cockett AT, di Sant'Agnese PA, Gopinath P, Schoen SR and Abrahamsson PA. (1993). Urology, 42, 512-519.
14. Cohen RJ, Glezerson G and Haffejee Z. (1991). Br. J. Urol., 68, 258-262.
15. Cowley S, Paterson H, Kemp P and Marshall CJ. (1994). Cell, 77, 841-852.
16. Cox ME, Deeble PD, Bissonette EA and Parsons SJ. (2000). J. Biol. Chem., 275, 13812-13818.
17. Cox ME, Deeble PD, Lakhani S and Parsons SJ. (1999). Cancer Res., 59, 3821-3830.
18. Deeble PD, Murphy DJ, Parsons SJ and Cox ME. (2001). Mol. Cell. Biol., 21, 8471-8482.
19. den Hertog J and Hunter T. (1996). EMBO J., 15, 3016-3027.
20. den Hertog J, Pals CE, Peppelenbosch MP, Tertoolen LG, de Laat SW and Kruijer W. (1993). EMBO J., 12, 3789-3798.
21. den Hertog J, Tracy S and Hunter T. (1994). EMBO J., 13, 3020-3032.
22. di Sant'Agnese PA. (1998a). Prostate Suppl., 8, 74-79.
23. di Sant'Agnese PA. (1998b). Urology, 51, 121-124.
24. di Sant'Agnese PA and Cockett AT. (1996). Cancer, 78, 357-361.
25. Diaz M, Abdul M and Hoosein N. (1998). Prostate Suppl., 8, 32-36.
26. Ferrell Jr JE. (1996). Curr. Top. Dev. Biol., 33, 1-60.
27. Fronsdal K, Engedal N and Saatcioglu F. (2000). Prostate, 43, 111-117.
28. Fukuda M, Gotoh Y, Tachibana T, Dell K, Hattori S, Yoneda Y and Nishida E. (1995). Oncogene, 11, 239-244.
29. Gioeli D, Mandell JW, Petroni GR, Frierson Jr HF and Weber MJ. (1999). Cancer Res., 59, 279-284.
30. Gkonos PJ, Krongrad A and Roos BA. (1995). Urol. Res., 23, 81-87.
31. Gredinger E, Gerber AN, Tamir Y, Tapscott SJ and Bengal E. (1998). J. Biol. Chem., 273, 10436-10444.
32. Greenlee RT, Hill-Harmon MB, Murray T and Thun M. (2001). CA Cancer J. Clin., 51, 15-36.
33. Hu X, Moscinski LC, Valkov NI, Fisher AB, Hill BJ and Zuckerman KS. (2000). Cell Growth Differ., 11, 191-200.
34. Ihara S, Nakajima K, Fukada T, Hibi M, Nagata S, Hirano T and Fukui Y. (1997). EMBO J., 16, 5345-5352.
35. Iwamura M, Abrahamsson PA, Foss KA, Wu G, Cockett AT and Deftos LJ. (1994). Urology, 43, 675-679.
36. Iwasaki S, Hattori A, Sato M, Tsujimoto M and Kohno M. (1996). J. Biol. Chem., 271, 17360-17365.
37. Jacob KK, Sap J and Stanley FM. (1998). J. Biol. Chem., 273, 4800-4809.
38. Jiang G, den Hertog J, Su J, Noel J, Sap J and Hunter T. (1999). Nature, 401, 606-610.
39. Jongsma J, Oomen MH, Noordzij MA, Van Weerden WM, Martens GJ, van der Kwast TH, Schroder FH and van Steenbrugge GJ. (2000). Cancer Res., 60, 741-748.
40. Kim J, Adam RM and Freeman MR. (2002). Cancer Res, 62, 1549-1554.
41. Lammers R, Moller NP and Ullrich A. (1997). FEBS Lett., 404, 37-40.
42. Lee LF, Guan J, Qiu Y and Kung HJ. (2001). Mol. Cell. Biol., 21, 8385-8397.
43. Lee MS, Igawa T, Yuan TC, Zhang XQ, Lin FF and Lin MF. (2003). Oncogene, 22, 781-796.
44. Lewis TS, Shapiro PS and Ahn NG. (1998). Adv. Cancer Res., 74, 49-139.
45. Lin MF and Clinton GM. (1986). Biochem. J., 235, 351-357.
46. Lin MF, Da Volio J and Garcia-Arenas R. (1992). Cancer Res., 52, 4600-4607.
47. Lin MF, Lee MS, Garcia-Arenas R and Lin FF. (2000). Cell. Biol. Int., 24, 681-689.
48. Lin MF, Lee MS, Zhou XW, Andressen JC, Meng TC, Johansson SL, West WW, Taylor RJ, Anderson JR and Lin FF. (2001). J. Urol., 166, 1943-1950.
49. Lin MF, Meng TC, Rao PS, Chang C, Schonthal AH and Lin FF. (1998). J. Biol. Chem., 273, 5939-5947.
50. Marshall CJ. (1995). Cell, 80, 179-185.
51. Meng TC and Lin MF. (1998). J. Biol. Chem., 273, 22096-22104.
52. Meng TC, Lee MS and Lin MF. (2000). Oncogene, 19, 2664-2677.
53. Mori S, Murakami-Mori K and Bonavida B. (1999). Biochem. Biophys. Res. Commun., 257, 609-614.
54. Noordzij MA, van Weerden WM, de Ridder CM, van der Kwast TH, Schroder FH and van Steenbrugge GJ. (1996). Am. J. Pathol., 149, 859-871.
55. Pang L, Sawada T, Decker SJ and Saltiel AR. (1995). J. Biol. Chem., 270, 13585-13588.
56. Price DT, Rocca GD, Guo C, Ballo MS, Schwinn DA and Luttrell LM. (1999). J. Urol., 162, 1537-1542.
57. Qiu Y, Robinson D, Pretlow TG and Kung HJ. (1998). Proc. Natl. Acad. Sci. USA, 95, 3644-3649.
58. Racke FK, Lewandowska K, Goueli S and Goldfarb AN. (1997). J. Biol. Chem., 272, 23366-23370.
59. Ruokonen M, Shan JD, Hedberg P, Patrikainen L and Vihko P. (1996). Biochem. Biophys. Res. Commun., 218, 794-796.
60. Schaeffer HJ and Weber MJ. (1999). Mol. Cell. Biol., 19, 2435-2444.
61. Seethalakshmi L, Mitra SP, Dobner PR, Menon M and Carraway RE. (1997). Prostate, 31, 183-192.
62. Seger R and Krebs EG. (1995). FASEB J., 9, 726-735.
63. Seuwen K and Pouyssegur J. (1990). Biochem. Pharmacol., 39, 985-990.
64. Shah GV, Rayford W, Noble MJ, Austenfeld M, Weigel J, Vamos S and Mebust WK. (1994). Endocrinology, 134, 596-602.
65. Shen R, Dorai T, Szaboles M, Katz AE, Olsson CA and Buttyan R. (1997). Urol. Oncol., 3, 67-75.
66. Su J, Muranjan M and Sap J. (1999). Curr. Biol., 9, 505-511.
67. Sundaram M and Han M. (1996). BioEssays, 18, 473-480.
68. Tarle M, Frkovic-Grazio S, Kraljic I and Kovacic K. (1994). Prostate, 24, 143-148.
69. Tetu B, Ro JY, Ayala AG, Johnson DE, Logothetis CJ and Ordonez NG. (1987). Cancer, 59, 1803-1809.
70. Theodorescu D, Broder SR, Boyd JC, Mills SE and Frierson Jr HF. (1997). Cancer, 80, 2109-2119.
71. Treisman R. (1996). Curr. Opin. Cell. Biol., 8, 205-215.
72. Tsai W, Morielli AD, Cachero TG and Peralta EG. (1999). EMBO J., 18, 109-118.
73. Umbhauer M, Marshall CJ, Mason CS, Old RW and Smith JC. (1995). Nature, 376, 58-62.
74. van Inzen WG, Peppelenbosch MP, van den Brand MW, Tertoolen LG and de Laat S. (1996). Brain Res. Dev. Brain Res., 91, 304-307.
75. Vossler MR, Yao H, York RD, Pan MG, Rim CS and Stork PJ. (1997). Cell, 89, 73-82.
76. Whalen AM, Galasinski SC, Shapiro PS, Nahreini TS and Ahn NG. (1997). Mol. Cell. Biol., 17, 1947-1958.
77. Xia Z, Dickens M, Raingeaud J, Davis RJ and Greenberg ME. (1995). Science, 270, 1326-1331.
78. Yao H, York RD, Misra-Press A, Carr DW and Stork PJ. (1998). J. Biol. Chem., 273, 8240-8247.
79. Zelivianski S, Comeau D and Lin MF. (1998). Biochem. Biophys. Res. Commun., 245, 108-112.
80. Zelivianski S, Dean J, Madhavan D, Lin FF and Lin MF. (2000). Mol. Cell. Biochem., 208, 11-18.
81. Zelivianski S, Verni M, Moore C, Kondrikov D, Taylor R and Lin MF. (2001). Biochim. Biophys. Acta., 1539, 28-43.
82. Zeng L, D'Alessandri L, Kalousek MB, Vaushan L and Pallen CJ. (1999). J. Cell. Biol., 147, 707-714.
83. Zhang XQ, Lee MS, Zelivianski S and Lin MF. (2001). J. Biol. Chem., 276, 2544-2550.
84. Zheng XM and Pallen CJ. (1994). J. Biol. Chem., 269, 23302-23309.
85. Zheng XM, Resnick RJ and Shalloway D. (2000). EMBO J., 19, 964-978.
86. Zi X and Agarwal R. (1999). Proc. Natl. Acad. Sci. USA, 96, 7490-7495.